Abstract:Objective To prepare the vascular endothelial grow th factor receptor 2 ( VEGFR2 )/Integrinαv β3 dual‐targeted contrast ultrasound agent ,and further evaluating the physical properties ,imaging characteristics and targeted ability in v itro . Methods VEGFR2 targeted microbubble ( MBV ) ,Integrinαv β3 targeted microbubble ( MBI) and VEGFR2/Integrinαv β3 dual targeted microbubble ( MBD) were prepared by attaching VEGFR2 antibody ,Integrinαv β3 antibody and both of VEGFR2/Integrinαv β3 antibody with no targeted USphere LA respectively , using biotin‐avidin linkage method . USphere LA with no antibody attached were used as non‐targeted microbubble( MBN ) . M icrobubble′s physical properties were observed , and its stability was detected by caculating bubble′s concentration at different time points . MBD′s ultrasound imaging characteristics were evaluated by comparing its grey level of ultrasound imaging with SonoVue at the time of preparation and 3 days after preparation . To detect the targeted ability of microbubble ,different types of microbubble were added into Hepa 1‐6 and C3H10 cells ,respectively . T he above procedure was repeated using the pre‐antibody blocking test in Hepa 1‐6 cell . Results MBD had a mean size of 1 256 nm .T he concentration of microbubble in the first duration of three days was declining slowly ,and its speed was accelerated after five days of preparation . T he grey level of new prepared MBD was similar to that of SonoVue in the same concentration ( P ＝0 .113) ,while the level was higher than that of SonoVue within 3 days after preparation( P ＜0 .001) . T he number of microbubble binding to Hepea1‐6 led a tendency of MBD＞ single targeted microbubble ＞ MBN ( all P ＜0 .05 ) . T he number of C3H10 and pre‐blocked Hepa1‐6 cell attached to each group of microbubble had no statistical difference ( all P ＞0 .05) . In addition ,following the pre‐blocked precedure ,the number of Hepa 1‐6 cell attached to each group of microbubble had no statistical difference either ( all P ＞ 0 .05 ) . Conclusions VEGFR2/Integrinαv β3 dual‐targeted contrast ultrasound agent is a stable microbubble and it has excellent ultrasound imaging and targeting ability in v itro .

Comparative study on contrast imaging and SR-BⅠ gene delivery of rat normal carotid artery of cationic liposomal microbubbles and SonoVue

Contrast Imaging and Gene Delivery Through the Combined Use of Novel Cationic Liposomal Microbubbles and Ultrasound in Rat Carotid Arteries

Comparative study on characteristics and enhanced ultrasonography of rat normal carotid artery of two ultrasound contrast agents loading SR-B

DNA-loaded Microbubbles with Crosslinked Bovine Serum Albumin Shells for Ultrasound-Promoted Gene Delivery and Transfection

Research of Ultrasound-Mediated Gene Delivery

Characteristics of VEGFR2-targeted Lipid Microbubbles Contrast-Enhanced Ultrasound in Nude Mice with Subcutaneous Colonic Carcinoma Xenografts: Compared with Lipid Microbubbles

[Synthesis of New Gene-Loaded Microbubbles Serve As Gene Delivery Vehicle Applied in Reporter Gene Transfer into Cardiac Myocytes].

Microsphere as a contrast agent/gene vector in ultrasound imaging-based vascular gene delivery

Preparation of Gene-Loaded Ultrasound Contrast Agent and Its in Vitro and in Vivo Enhancement Effects

Use of Cationic Microbubbles Targeted to P-selectin to Improve Ultrasound-Mediated Gene Transfection of Hvegf165 to the Ischemic Myocardium

Hypolipidemic Effect of SR-BI Gene Delivery by Combining Cationic Liposomal Microbubbles and Ultrasound in Hypercholesterolemic Rats

Acoustic Characterization and Enhanced Ultrasound Imaging of Long-Circulating Lipid-Coated Microbubbles.

In vivo US monitoring of catheter-based vascular delivery of gene microspheres in pigs: feasibility.

Magnetic Resonance Imaging Permits In Vivo Monitoring Of Catheter-Based Vascular Gene Delivery

3.0-T Mr Imaging of Intracoronary Local Delivery of Motexafin Gadolinium into Coronary Artery Walls

Ultrasound microbubble contrast agents: Application to therapy for peripheral vascular disease

Construction Methods and Its Efficiency of the Delivery Vehicle: Complex of SonoVue Conjugated to Liposomes

Preparation of Vascular Endothelial Growth Factor Receptor 2/integrinαv Β3 Dual‐targeted Contrast Ultrasound Agent and Its Ultrasound Imaging Features and Targeted Ability :A in Vitro Study

Progress and preclinical application status of ultrasound microbubbles

Application of Targeted Nano-Bubble Ultrasound Contrast Agent in the Detection of Arterial Intima Inflammation in Rats

[Investigation in vivo of effect of ultrasound-mediated microbubble destruction on entrance of feridex into the aortal wall]